Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schoemaker

Showing results (321-330 of 360) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
American Journal of Human Genetics|September 20, 2016
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 RegulationMaya Ghoussaini, Juliet D French, Kyriaki Michailidou, et al.
The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.
Cancer Research|March 12, 2017
<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast CancerHermela Shimelis, Romy L S Mesman, Catharina Von Nicolai, et al.
American Journal of Human Genetics|June 16, 2015
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionHatef Darabi, Karen McCue, Jonathan Beesley, et al.
Carcinogenesis|January 15, 2015
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancerMaria Kabisch, Justo Lorenzo Bermejo, Thomas Dünnebier, et al.
Journal of the National Cancer Institute|May 3, 2020
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer RiskPooja Middha Kapoor, Nasim Mavaddat, Parichoy Pal Choudhury, et al.
British Journal of Cancer|August 3, 2021
Mendelian randomisation study of smoking exposure in relation to breast cancer riskHanla A Park, Sonja Neumeyer, Kyriaki Michailidou, et al.
Pageof 36

Showing results (321-330 of 360) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
American Journal of Human Genetics|September 20, 2016
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 RegulationMaya Ghoussaini, Juliet D French, Kyriaki Michailidou, et al.
The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.
Cancer Research|March 12, 2017
<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast CancerHermela Shimelis, Romy L S Mesman, Catharina Von Nicolai, et al.
American Journal of Human Genetics|June 16, 2015
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionHatef Darabi, Karen McCue, Jonathan Beesley, et al.
Carcinogenesis|January 15, 2015
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancerMaria Kabisch, Justo Lorenzo Bermejo, Thomas Dünnebier, et al.
Journal of the National Cancer Institute|May 3, 2020
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer RiskPooja Middha Kapoor, Nasim Mavaddat, Parichoy Pal Choudhury, et al.
British Journal of Cancer|August 3, 2021
Mendelian randomisation study of smoking exposure in relation to breast cancer riskHanla A Park, Sonja Neumeyer, Kyriaki Michailidou, et al.
Pageof 36